Andrea Coviello is an Endocrinology/Metabolic physician. OpenAlex indexes 96 publications with 9,929 citations (h-index 39).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
732 Harrison Avenue
Preston, 2nd Floor
Boston, MA 021182309
Telephone
617-638-7470Provider last certified this registry record 15 Aug 2023.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year20257 payments$16,506openpaymentsdata.cms.gov ↗
- Novo Nordisk IncProgram year20253 payments
- Novo Nordisk IncProgram year20247 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
66.1%GLP-1 receptor agonist45.3%Mounjaro60%Ozempic41%Part D≥32 patientsBiguanide (metformin)10.6%Metformin Hcl Er81%Metformin Hcl19%Part D<11 patients+ 2 more classes in this area
Nervous system
21.9%Other antiepileptics16.5%Topiramate100%Part D≥32 patientsAminoketone5.4%Bupropion Xl63%Bupropion Hcl37%Part D<11 patientsHormonal (systemic)
6.4%l-Thyroxine6.4%Levothyroxine Sodium71%Synthroid29%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2009–2012 per NIH RePORTER. The latest:
- Clinical Correlates of High and Low Testosterone in Women: Framingham Heart Study
Boston University Medical Campus
FY2012$439,889R01HL094755 - Clinical Correlates of High and Low Testosterone in Women: Framingham Heart Study
Boston University Medical Campus
FY2010$377,379R01HL094755 - Clinical Correlates of High and Low Testosterone in Women: Framingham Heart Study
Boston Medical Center
FY2009$473,730R01HL094755
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists
American Journal of Preventive Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”